Dear Sir/Madam,
We invite you to participate in the multicenter observational study entitled "Early treatment of heart failure: a non-interventional observational study of patients with heart failure who initiated dapagliflozin therapy in CEE-BA (EVOLUTION-HF)", which aims to describe the characteristics of patients initiating dapagliflozin therapy for heart failure with reduced ejection fraction (HFrEF) and provide early insights into real-world treatment patterns with this agent.
To start the study, it is necessary to conclude an online agreement, so please register and follow the instructions that appear on the computer screen.
